Boule Diagnostics Aktie (A2JMYV

Was macht Boule Diagnostics?

Unternehmensprofil

Boule Diagnostics AB engages in the development, manufacture, sale and marketing of instruments and consumable products for blood diagnostics. It offers automated blood cell counting systems for both the global human and veterinary market. The company was founded in 1992 and is headquartered in Spanga, Sweden.

Chart der Boule Diagnostics Aktie

Charttool öffnen

Aktuelle Nachrichten zu Boule Diagnostics

Weitere Nachrichten

Das berichten andere über Boule Diagnostics

Boule Diagnostics AB (publ) 2025 Q4 - Results - Earnings Call Presentation

Boule Diagnostics AB (publ) (BDABF) Q4 2025 Earnings Call Prepared Remarks Transcript

Boule Diagnostics Enters Distribution Agreement with VitalScientific

Boule Diagnostics AB (publ), a global leader in Hematology solutions, is pleased to announce that it has entered into an exclusive distribution agreement with VitalScientific...

Boule Diagnostics interim report Q2 2024

Stable development and improved margins Quarter April - June 2024 · Net sales amounted to SEK 137.0 million (140.5), corresponding to a decrease of 2.5 percent. Organic...